Skip to nav Skip to content

IDSA Practice Guideline Highlights & Status

Facebook Twitter LinkedIn Email

Listed below is a summary of 2022, 2023, and 2024 highlights for IDSA guidelines as well as guidelines endorsed by IDSA.

Guideline

Publication Date

Journal

Guidelines Released in 2024
Primary Care Guidance Update (Joint with HIVMA) 10/2024 Clinical Infectious Diseases
COVID:19 Treatment and Management (Focused Guideline Update: Pemivibart) 8/2024 IDSA & Clinical Infectious Diseases
Antimicrobial Resistance Update 7/2024 IDSA & Clinical Infectious Diseases
Intra-abdominal Infections (Multi-Part Series: Part 1) 6/2024 IDSA & Clinical Infectious Diseases
Lab ID Guidance (Joint with ASM) 3/2024 Clinical Infectious Diseases

Updates to COVID-19 guidelines:

Diagnostics: Serology

2/2024

IDSA & Clinical Infectious Diseases

Guidelines Released in 2023
Bone and Joint Infections: Acute Bacterial Arthritis in Pediatrics  11/2023 IDSA & Pediatric Infectious Diseases Society
New Fever in Critically Ill Patients 11/2023 IDSA & Society of Critical Care Medicine 
Diabetic Foot Infections 10/2023 Clinical Infectious Diseases & Diabetes/Metabolism Research and Reviews
Antimicrobial Resistance Update 6/2023 IDSA & Clinical Infectious Diseases
Compendia on Catheter-Associated Urinary Tract Infections 6/2023 Infection Control & Hospital Epidemiology

Hepatitis C Guidance Update

5/2023 IDSA & Clinical Infectious Diseases

SHEA/IDSA/APIC Compendia Updates:

Prevent Healthcare-Associated Infections Through Hand Hygiene

2/2023

 

 

 

Infection Control & Infectious Diseases

 

 

 

Clostridioides Difficile Infections

4/2023

Surgical Site Infections

5/2023

Methicillin-Resistant Staphylococcus aureus

6/2023

Updates to COVID-19 Guidelines:

Treatment and Management

6/2023

IDSA & Clinical Infectious Diseases

Diagnostics: Antigen Testing

1/2023

Diagnostics: Molecular 

9/2023

Guidelines Released in 2022
Updated Guidance on Antimicrobial-Resistant Gram-Negative Infections, v1.1: ESBL-E, CRE, and Pseudomonas aeruginosa with Difficult-to-Treat Resistance 3/2022 IDSA & Clinical Infectious Diseases
Updates to COVID-19 Guidelines:
Treatment and Management 9/2022

IDSA & Clinical Infectious Diseases

Diagnostics: Antigen Testing 12/2022
SHEA/IDSA/APIC Compendia Updates:
Central Line-associated Bloodstream Infections 4/2022

Infection Control & Hospital Epidemiology

Ventilator-associated Pneumonia, Ventilator-associated Events, and Nonventilator Hospital-acquired Pneumonia  5/2022

 

Listed below is a summary of IDSA guidelines in development and topics prioritized for future development.

Guideline

Publication Date (Estimated)

Journal

Guidelines in Development
Antimicrobial Prophylaxis in Surgery (Joint with ASHP/SHEA/SIS) 2024, Q4 American Journal of Health-System Pharmacy
Aspergillosis (Multi-Part Series) 2025, Q1 (Part 1) Clinical Infectious Diseases
Community-Acquired Pneumonia in Adults (Joint with ATS) 2025, Q2 American Journal of Respiratory and Critical Care Medicine
Community-Acquired Pneumonia in Children (Joint with PIDS) 2025, Q1 Clinical Infectious Diseases
Diagnosis and Management of HAP/VAP (Joint with ATS) 2025, Q4 Clinical Infectious Diseases
Drug-Susceptible and Drug-Resistant Tuberculosis (Joint with ATS/ERS/CDC) 2025, Q2 American Journal of Respiratory and Critical Care Medicine
HBV (Joint with AASLD) 2024, Q4 Hepatology
HCV (Joint with AASLD) 2024, Q4 Hepatology
Histoplasmosis (Multi-Part Series) 2024, Q4 (Part 1) Clinical Infectious Diseases
Immunomodulators 2025, Q1 Clinical Infectious Diseases
IV Catheter 2024, Q4 Clinical Infectious Diseases
Staphylococcus aureus Bacteremia (Joint with ESCMID) (Multi-Part Series) 2024, Q4 Clinical Infectious Diseases
Strep Pharyngitis (Multi-Part Series) 2024, Q4 (Part 1) Clinical Infectious Diseases
Treatment of Uncomplicated Urinary Tract Infections (Multi-Part Series) 2024, Q4 (Part 1) Clinical Infectious Diseases

Updates to COVID-19 Guidelines:

Treatment and Management

Ongoing IDSA & Clinical Infectious Diseases
Guidelines Prioritized for Development
Diagnosis and Management of Prosthetic Joint Infections TBD TBD
Diagnosis and Management of Skin and Soft Tissue Infections TBD TBD
Management of Enterococcal Infections (including Vancomycin-Resistant Enterococcus) (NEW TOPIC) TBD TBD

 

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.